ABA CLE on Biotechnology and the Law

The American Bar Association will be offering a two-part webcast entitled: "Biotechnology and the Law: A Primer."  Part I will be held on May 31, 2007 from 1:00-2:30 PM (EST), and Part II will be held on June 7, 2007 from 1:30-2:30 PM (EST).  The two-part webcast is based on the book "Biotechnology and the Law," which the webcast's speakers recently released.

In Part I of the webcast, speakers Hugh B. Wellons of LeClair Ryan, Eileen Smith Ewing of K&L Gates, and William Wofford of the Hutchison Law Group will cover the fundamentals of corporate structure; address issues involved in starting up a biotech company, including staffing and the acquisition of intellectual property and financing; and discuss research, development, and collaborations.

In Part II of the webcast, speakers Hugh B. Wellons of LeClair Ryan, Robert F. Copple of Copple & Associates, Erika Lietzan of Covington & Burling, and Christine C. Vito of K&L Gates will provide an overview of the regulatory approval process for pharmaceutical and biologic products, describe how patent prosecution and litigation impact the success or failure of a biotech company, and discuss strategies to help minimize and manage litigation risks.  Although Part II of the webcast will primarily focus on U.S. legal issues, the speakers will also touch on certain aspects of European and other foreign laws that can affect a biotech company's prospects for success.

Those interested in registering for Part I, can do so here (individuals) or here (groups), and those interested in registering for Part II, can do so here (individuals) or here (groups).  The registration fee for each webcast ranges from $85 to $150.  Discounted rates are available for those interested in registering for both webcasts.